CIMAP2
Ciliary microtubule-associated protein 2
Also known as: C1orf177, CMAP2_HUMAN, FLJ40201, LEM, LEXM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3ZCV2
- Gene
- CIMAP2
- Ensembl
- ENSG00000162398
- Chromosome
- 1
- Canonical length
- 418 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for CIMAP2 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
418 residues, UniProt reviewed canonical sequence.
>Q3ZCV2|CIMAP2
1 MRESQDAAGA HGWNRVGSTA TKWFTGAPFG VQSHRFDISA VYPNWKKFST FTEAPYSTRY
61 STQVSHIGPG TYSSKETCFS KKKLMKEVDT GWAKAQEATR LTQLPHFQYQ AIMKEKRLKE
121 QKLGPGSYNL KDFLEQLREK PCSTRGLLSS GEVRFRGLTG NYYPGPGNYG EKGNPYTKLE
181 ENAWNRSHSE GLMCRMSNKP HPRPHQGSGL GPGTYFFKSD LETYVARSVG TRGPYDTFSG
241 DRSKPLPYGH YSMQKKKPRE LMNFKSFVEE LNSHHNKKHG VFSKLPRNPK TPTERIYWAN
301 LSQCPRTLAT SGPSFWLPQE KKCKPVNQPP FLLTSKGSGA KACQMIMGSW NPVGVGRYLN
361 TWLMETKDRR QRYRSLFLSG SKRYLSDLAR DMLMQERITP FTKGKCPPTV DYNSDPTPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CIMAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 12 nTPM
- testis: 4.5 nTPM
- vagina: 4.1 nTPM
- cervix: 2.9 nTPM
- duodenum: 1.5 nTPM
- small intestine: 1.2 nTPM
Single-cell type
- esophageal apical cells: 247 nCPM
- late spermatids: 61 nCPM
- early spermatids: 56 nCPM
- nk-cells: 16 nCPM
- esophageal suprabasal cells: 10 nCPM
- enterocytes: 10 nCPM
Immune cell
- gdT-cell: 3.7 nTPM
- naive CD8 T-cell: 2.4 nTPM
- NK-cell: 2 nTPM
- memory CD8 T-cell: 1.9 nTPM
- total PBMC: 1 nTPM
- eosinophil: 0.9 nTPM
Brain region
- basal ganglia: 4.2 nTPM
- medulla oblongata: 1.3 nTPM
- hypothalamus: 1 nTPM
- pons: 1 nTPM
- cerebellum: 0.8 nTPM
- cerebral cortex: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Ciliary microtubule-associated protein 2
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CIMAP2 as an antibody target. Whether an autoantibody or antibody against CIMAP2 could matter depends on whether native CIMAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CIMAP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CIMAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...